In our carefully considered opinion, the available data on Ivermectin is quite adequate. There is no need to await the outcome of further trials. Any call for local trials prior to approval is unnecessary, as neither time, resources, nor ethical approval would permit.
TrialSite hosted the first international Ivermectin for Covid Summit webinar on Sunday, May 23rd 2021. The event was widely attended with medical experts presenting from around the world to a global audience of interested parties in the thousands.
“Tackling the pandemic probably requires, in addition to a vaccine, a preventive or early-acting drug. This drug also helps especially in a situation where vaccine coverage threatens to remain too low for herd immunity,” said Väänänen.
TrialSite hosted the first international Ivermectin for Covid Summit webinar on Sunday, May 23rd 2021. The event was widely attended with medical experts presenting from around the world to a global audience of interested parties in the thousands.
A medical doctor and scientist, Dr Urso is one of the most prominent C19 doctors in the US. Since March 2020, he has treated hundreds of patients at home, on an ambulatory basis. In this interview, he tells us about his experience, about C19 in Texas and about the America’s Frontline Doctors movement.
Leading the national trial is Dr. Carolyn Bramante, a U internal medicine specialist. Emphasizing the importance of this trial, she says, “Not everybody has access to the vaccine, whereas these medications are existing generics, already FDA-approved, that are available in most pharmacies around the world.” Dr. Bramante continued, “If we find evidence of benefit, [the drugs] could be used immediately anywhere.”
Dr Richard Urso uncovers a hugely significant detail in a chloroquine study. Chloroquine will protect a normal cell & let the virus attack a cancer cell.
Doctors have found safe, effective and inexpensive treatments that work well in preventing and treating patients with COVID-19 like Ivermectin that’s been used safely for more than 30 years.
But the government has not supported the use of this effective drug. In fact, there are other therapies like hydroxychloroquine, vitamins D and C and zinc that physicians have found to be safe and effective in preventing and treating COVID.
Dr. Pierre Kory explain both the case that ivermectin (IVM) effectively prevents or treats COVID-19, and also how and why that information is withheld by public health officials.
But while political psychology did its thing, making HCQ a no go zone for many physicians, Tyson and his staff simply treated patients according to whatever seemed to work, using HCQ as a primary option. And work it did.
Both Goa and Karnataka are rolling out mass Ivermectin programs in a bid to reduce infection, transmission, and death rates associated with COVID-19. TrialSite reported two days ago that the State of Goa embraced the national Ivermectin guidelines, and as reported in The Mint and other outlets, Vishwajit Rane, Goa’s Health Minister, declared that all people 18 years and up would have access to the generic drug regardless of COVID-19 status in an aggressive bid to lower infection rates and total deaths associated with SARS-CoV-2.
Today, the health experts tasked at the political levels of the United States (and by chance those nations closest to its sphere of influence) are failing us by dismissing an avalanche of evidence of effective empiric COVID-19 treatments, primarily at the early stages of disease.
Source: Francesoir Italy has been talked about a lot since the start of the Covid crisis in 2020 with first of all a significant mortality
We are very honored to present this interview of Dr Vladimir Zelenko, the father of outpatient treatment for COVID-19 in North America. Dr Zelenko shares his own experience with COVID-19 as a patient, as he is recovering from a severe form of the disease.
He also talks about his cancer and how he was able to go through this dramatic episode of his life. Then, he presents his perspectives about outpatient treatment as practiced today and the evolution of the pandemic, among other topics.
Famous actor, Louis Gosset Jr. and his physician, Dr. Bruce Boros, share their experience with a life saving treatment against Covid.
Significant QT prolongation was not observed during the follow‐up period compared with the baseline values in the present study. No ventricular arrhythmias, second and third‐degree heart blocks, or severe pauses were recorded during the treatment period.
At this point, continuing the use of Ivermectin has proven safe and we see no reason to stop this drug, which seems to have not only inhibited our second wave but so far prevented a third one.
“The Minister of Health, Marcelo Queiroga, has announced that he will soon launch a protocol of drugs to be used in the treatment against Covid-19. ”
This guide, which should guide health workers, has, as likely drugs, hydroxychloroquine and ivermectin.
Today, most leading doctors in India are themselves not promoting the Ministry of Health guidelines that includes the use of hydroxychloroquine, ivermectin and inhaled budesonide.
Dr. George Fareed interviews a 47-year-old patient who had Covid-19 and co-morbidities. He was at high risk and survived thanks to his early treatment regime. The patient’s treatment protocol included hydroxychloroquine, ivermectin, doxycycline, and Vitamin D.
“It [nomination for the Nobel Peace Prize] gives credibility to the message,” Dr. Zelenko said. “Which is, treat Covid-19 early and live.”
n a recent interview, Dr. Stone recently shared that while the death rate climbed much higher in January, again peaking at 70 deaths on the 25th of that month, Official authorization for the use of ivermectin was granted a day later.
A month later, the number of deaths fell to zero. Again, the correlation here along with Dr. Stone’s direct clinic experience is ivermectin sales. Over 500,000 doses of the generic, FDA-approved drug were administered from December through February. This compares to 1,057 bottles turned over in January 2020.
Independent Federal MP Craig Kelly has hit back at Facebook after it permanently deleted his official page. “This is the electronic version of book burning where they simply don’t like what I say,” he told Ben Fordham.
If you were going to try and design a drug, for the disease that we call COVID-19, you would want something with heavy anti-viral properties, as well as anti-inflammatory properties.
When you think about that, it’s hard to come up with a better drug for Covid than ivermectin. It literally does both of those things simultaneously, and it’s one of the safest drugs known to man.
Medical experts from around the world joined together to present the very latest real world research on repurposing this safe drug that has the ability to transform global efforts to fight the pandemic. Prof. Héctor Carvallo shares his experiences with using ivermectin for long covid in Argentina.
The International Ivermectin for Covid Conference: Dr. Wasif Khan presents his published ivermectin trial and his experience with using ivermectin in Bangladesh.
Medical experts from around the world joined together to present the very latest real world research on repurposing this safe drug that has the ability to transform global efforts to fight the pandemic. Prof. Pierre Kory discusses current protocols for covid-19 prevention and treatment.
The International Ivermectin for Covid Conference: Professor Eli Schwartz shares data and conclusions from his Israeli randomised controlled trial of ivermectin in mild to moderate covid-19.
British Ivermectin Recommendation Development (BIRD) is campaigning for UK approval for ivermectin to help it beat Covid. Dr Tess Lawrie wraps up their first International ivermectin conference. This is her powerful and impassioned speech.
As Head of the Department of Medical Ethics and Law, Medical Faculty, University of Maribor, Slovenia, Prof. Matjaž Zwitter presents current ethical issues around ivermectin for covid-19. His two papers on ivermectin for Covid-19, as published in Slovenian medical journal Isis and in leading newspaper Delo stirred a vivid debate among medical and lay community, hopefully leading to a change in current medical practice.
Dr. Manjul Medhi shares his front-line experiences in treating acute and long covid including using ivermectin in patients at risk of disseminated strongyloides infection.
The first-ever conference focusing on the use of ivermectin (IVM) as a prophylaxis and treatment for covid-19 was held online April 24-25 2021. Dr Tina Peers, UK GP describes her real-world experiences treating Long Covid.
The International Ivermectin for Covid Conference: Dr. David Chesler shares his experience of using ivermectin to prevent and treat covid-19 infection amongst care home residents.
Medical experts from around the world joined together to present the very latest real world research on repurposing ivermectin that has the ability to transform global efforts to fight the pandemic. Mr. Andrew Bryant provides an overview of ongoing trials and what they may add to the evidence base.
The International Ivermectin for Covid Conference:
Dr. Tess Lawrie presents the latest systematic review evidence from RCTs and a selection of resource, equity, acceptability and feasibility considerations related to ivermectin use for COVID-19
Medical experts from around the world joined together to present the very latest real world research on repurposing this safe drug that has the ability to transform global efforts to fight the pandemic. In this talk, speaker Dr. Mobeen Syed provides an overview of ivermectin and how it works against covid-19.
So, what’s different between Maharashtra and Delhi with respect to the rest of India and South Asia? Instead of relying on HCQ and IVM, many doctors and health officials in Maharashtra and Delhi pushed the expensive and profitable remdesivir drug. Due to its cost and recommended time of usage, remdesivir is not used either as a prophylaxis or for early outpatient treatment. And unlike the cheap and easy-to-produce HCQ and IVM, remdesivir is difficult to replace when it runs out.
HCQ is effective for COVID-19. The probability that an ineffective treatment generated results as positive as the 235 studies to date is estimated to be 1 in 6 quadrillion (p = 0.00000000000000018).
Early treatment is most successful, with 100% of 29 studies reporting a positive effect (13 statistically significant in isolation) and an estimated reduction of 65% in the effect measured (death, hospitalization, etc.) using a random effects meta-analysis, RR 0.35 [0.25-0.50].
92% of Randomized Controlled Trials (RCTs) for early, PrEP, or PEP treatment report positive effects, the probability of this happening for an ineffective treatment is 0.0017.
With a surge of SARS-CoV-2 infections and a vaccination drive totaling 1.3 million, the nation’s leadership faces an uphill battle when factoring in their total population of 108 million. Hence the growing interest in ivermectin and the request of hospitals for access to the drug for compassionate use.
